Arrivent Biopharma Inc
- Fund Information and Directors
| Arrivent Biopharma Inc |
| Firm |
|
| Fund # | |
| CIK # | 0001868279 |
| Sale | 2022-12-16
($145.0 M Offered, $110.0 M Sold)
|
| Fund | |
| Phone | 2407806356 |
| Address | 18 Campus Blvd
Newtown Square, Pennsylvania 19073-3269 |
| Source |
[EDGAR]
|
| Fund AUM and Sold ($M) |
|
|
| Fund Details |
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction | |
{"search": "/search", "clicked": "/clicked", "portfolio_add": "/portfolio-add", "portfolio_remove": "/portfolio-remove", "portfolio_create": "/portfolio-create", "portfolio_activate": "/portfolio-activate", "portfolio_delete": "/portfolio-delete", "portfolio_rename": "/portfolio-rename", "portfolio_color": "/portfolio-color", "home_filter": "/home-filter", "htmlspeed": "/htmlspeed", "add_tag_firm": "/add-tag-firm", "add_tag_click": "/add-tag-click", "copy_aum": "/copy-aum", "stripe_checkout": "/stripe-checkout", "update_card": "/update-card"}
{"uid": 161604661, "pid": -1, "pid_a": [], "name": "", "email": "", "blacklist_f": false, "paywall_f": false, "paywall_n": 0, "random_n": 0}
False
234574536